[Testicular lymphoma in two patients with AIDS and two without AIDS]

L G Pérez-Santos1, A Gamboa-Domínguez, H Guzmán-Rodríguez

  • 1Instituto Nacional de la Nutrición Salvador Zubirán, México, D.F., México.

Insights

Testicular non-Hodgkin lymphomas are aggressive in AIDS patients. These B-cell lymphomas, negative for Epstein-Barr virus, showed poor outcomes in HIV-positive individuals.

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Testicular non-Hodgkin lymphoma (NHL) is rare.
  • Clinical, morphological, and immunophenotypic characteristics require further elucidation.

Purpose of the Study:

  • To describe the clinical, morphological, and immunophenotypic characteristics of testicular NHL.
  • To report on the follow-up of patients diagnosed with testicular NHL at a referral center.

Main Methods:

  • Retrospective review of testicular lymphoma cases from 1987 to 1997.
  • Immunohistochemical studies including CD45, CD20, CD43, Epstein-Barr virus latent membrane protein, and UCHL-1.
  • Statistical analysis using the Fisher exact test.

Main Results:

  • Four cases of testicular lymphoma (7.5% of testicular tumors) were identified.
  • Two cases occurred in patients with AIDS, presenting with more aggressive local invasion and systemic progression.
  • All four lymphomas were B-cell lineage, negative for Epstein-Barr virus latent membrane protein.
  • Non-AIDS patients had favorable outcomes, while AIDS patients died within 1-3 months.

Conclusions:

  • Testicular NHL in this cohort was of B-cell origin and EBV-negative.
  • AIDS-associated testicular lymphoma exhibited a more aggressive clinical course and poorer prognosis.
Abstract